APP and Alzheimer disease: Elevated LPO products such as MDA and 4-HNE are consistently observed in AD brains (304), and dietary supplementation with deuterated PUFAs (D-PUFAs) prevents LPO and reduces toxic Aβ levels in APP/PS1 mice (305).